GBR-12935: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== GBR-12935 == | |||
[[File:GBR-12935.svg|thumb|right|Chemical structure of GBR-12935]] | |||
GBR-12935 | |||
'''GBR-12935''' is a chemical compound that acts as a potent and selective [[dopamine reuptake inhibitor]]. It is primarily used in scientific research to study the [[dopaminergic system]] and its role in various [[neurological disorders]]. | |||
GBR-12935 | |||
== | === Chemical Properties === | ||
GBR-12935 is | GBR-12935 is a piperazine derivative, and its chemical structure is characterized by a [[piperazine]] ring linked to a [[phenyl]] group and a [[tropane]] moiety. The compound is known for its high affinity for the [[dopamine transporter]] (DAT), which it inhibits, leading to increased levels of [[dopamine]] in the [[synaptic cleft]]. | ||
== | === Mechanism of Action === | ||
GBR-12935 functions by binding to the dopamine transporter, thereby blocking the reuptake of dopamine into the presynaptic neuron. This inhibition results in elevated extracellular concentrations of dopamine, enhancing dopaminergic neurotransmission. This mechanism is similar to that of other dopamine reuptake inhibitors, such as [[cocaine]], but GBR-12935 is more selective and is primarily used in research settings. | |||
== | === Research Applications === | ||
GBR-12935 is extensively used in [[neuroscience]] research to investigate the role of dopamine in the brain. It is particularly useful in studies related to [[Parkinson's disease]], [[schizophrenia]], and [[addiction]]. By modulating dopamine levels, researchers can better understand the pathophysiology of these conditions and evaluate potential therapeutic interventions. | |||
=== Pharmacological Effects === | |||
The pharmacological effects of GBR-12935 are primarily related to its action on the dopaminergic system. In animal models, it has been shown to increase locomotor activity and produce behavioral effects similar to those of psychostimulants. These effects are valuable for studying the behavioral and neurochemical consequences of altered dopamine transmission. | |||
=== Safety and Toxicity === | |||
As a research chemical, GBR-12935 is not intended for human consumption, and its safety profile in humans is not well-established. In laboratory settings, it is handled with care to avoid exposure, and its use is typically restricted to controlled environments. | |||
== Related Pages == | |||
* [[Dopamine transporter]] | * [[Dopamine transporter]] | ||
* [[Dopamine reuptake inhibitor]] | * [[Dopamine reuptake inhibitor]] | ||
* [[ | * [[Neurotransmitter]] | ||
* [[Psychostimulant]] | |||
[[Category:Research chemicals]] | [[Category:Research chemicals]] | ||
[[Category:Dopamine reuptake inhibitors]] | |||
Latest revision as of 03:35, 13 February 2025
GBR-12935[edit]
GBR-12935 is a chemical compound that acts as a potent and selective dopamine reuptake inhibitor. It is primarily used in scientific research to study the dopaminergic system and its role in various neurological disorders.
Chemical Properties[edit]
GBR-12935 is a piperazine derivative, and its chemical structure is characterized by a piperazine ring linked to a phenyl group and a tropane moiety. The compound is known for its high affinity for the dopamine transporter (DAT), which it inhibits, leading to increased levels of dopamine in the synaptic cleft.
Mechanism of Action[edit]
GBR-12935 functions by binding to the dopamine transporter, thereby blocking the reuptake of dopamine into the presynaptic neuron. This inhibition results in elevated extracellular concentrations of dopamine, enhancing dopaminergic neurotransmission. This mechanism is similar to that of other dopamine reuptake inhibitors, such as cocaine, but GBR-12935 is more selective and is primarily used in research settings.
Research Applications[edit]
GBR-12935 is extensively used in neuroscience research to investigate the role of dopamine in the brain. It is particularly useful in studies related to Parkinson's disease, schizophrenia, and addiction. By modulating dopamine levels, researchers can better understand the pathophysiology of these conditions and evaluate potential therapeutic interventions.
Pharmacological Effects[edit]
The pharmacological effects of GBR-12935 are primarily related to its action on the dopaminergic system. In animal models, it has been shown to increase locomotor activity and produce behavioral effects similar to those of psychostimulants. These effects are valuable for studying the behavioral and neurochemical consequences of altered dopamine transmission.
Safety and Toxicity[edit]
As a research chemical, GBR-12935 is not intended for human consumption, and its safety profile in humans is not well-established. In laboratory settings, it is handled with care to avoid exposure, and its use is typically restricted to controlled environments.
